Usp44-flox Mouse
Common Name
Usp44-flox
제품 ID
S-CKO-10539
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-327799-Usp44-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Usp44-flox Mouse (카탈로그 번호 S-CKO-10539)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Usp44-flox
품종 계통계통 ID
CKOCMP-327799-Usp44-B6J-VA
유전자명
제품 ID
S-CKO-10539
유전자 별칭
E430004F17Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 10
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000216224
NCBI 전사체 ID
NM_001400981
타겟 영역
Exon 2
유효 영역 크기
~2.7 kb
유전자 연구 개요
Usp44, a member of the ubiquitin-specific proteases (USPs) family, functions as a deubiquitinase. It participates in multiple biological processes by regulating the deubiquitination of various substrates, influencing pathways related to DNA repair, immune cell function, and cancer-related signaling [5].
In nasopharyngeal carcinoma, Usp44 is hypermethylated and down-regulated. It enhances radiotherapy sensitivity by recruiting and stabilizing TRIM25, which degrades Ku80 and inhibits non-homologous end-joining DNA repair. Knockout of TRIM25 reverses this radiotherapy sensitization effect, suggesting its role in tumor suppression [1].
In regulatory T cells (Tregs), Usp44 promotes Treg function during inflammation by preventing the degradation of FOXP3, an essential transcription factor for Tregs. Tregs lacking Usp44 are less effective in vitro and in vivo [2].
In hepatocellular carcinoma, Usp44 suppresses tumor progression by inhibiting the Hedgehog signaling pathway and PDL1 expression. It interacts with Itch, promoting Itch's deubiquitination and stabilization, leading to Gli1 degradation and inactivation of the pathway [3].
In neuroblastoma, high levels of Usp44 are associated with aggressive disease features. Depletion of the histone H2B ubiquitin ligase subunit RNF20, similar to Usp44 depletion, affects cell proliferation, migration, and invasion, indicating histone H2B as a potential target of Usp44 [4].
In breast cancer, hypermethylation of Usp44 leads to poor expression, and its overexpression suppresses cancer cell proliferation, migration, and invasion [6].
In cholangiocarcinoma, MAD2 interferes with the USP44/LIMA1 complex, promoting cancer progression [7].
In thyroid cancer, Usp44 inactivation accelerates tumor progression by inducing p21 ubiquitylation and degradation [8].
In oral squamous cell carcinoma, Usp44 acts as a tumor suppressor by stabilizing HEXIM1 protein and inhibiting cell proliferation and metastasis [9].
In conclusion, Usp44 plays crucial roles in various biological processes and disease conditions. Through gene knockout or other loss-of-function models in different cancers, it has been revealed that Usp44 can act as a tumor suppressor in many cases, influencing DNA repair, immune cell function, and cancer-related signaling pathways. Understanding Usp44's functions helps in exploring potential therapeutic targets for cancers such as nasopharyngeal carcinoma, hepatocellular carcinoma, and others.
References:
1. Chen, Yang, Zhao, Yin, Yang, Xiaojing, Ma, Jun, Liu, Na. 2022. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. In Nature communications, 13, 501. doi:10.1038/s41467-022-28158-2. https://pubmed.ncbi.nlm.nih.gov/35079021/
2. Yang, Jing, Wei, Ping, Barbi, Joseph, Pan, Fan, Li, Bin. 2020. The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation. In EMBO reports, 21, e50308. doi:10.15252/embr.202050308. https://pubmed.ncbi.nlm.nih.gov/32644293/
3. Chen, Sisi, Zhou, Binghai, Huang, Wei, Wang, Wei, Xie, Peiyi. 2023. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression. In Cell death & disease, 14, 830. doi:10.1038/s41419-023-06358-y. https://pubmed.ncbi.nlm.nih.gov/38097536/
4. Ekstrom, Thomas L, Hussain, Sajjad, Bedekovics, Tibor, Johnsen, Steven A, Galardy, Paul J. . USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming. In Molecular cancer research : MCR, 22, 812-825. doi:10.1158/1541-7786.MCR-23-0454. https://pubmed.ncbi.nlm.nih.gov/38775808/
5. Lou, Yuming, Ye, Minfeng, Xu, Chaoyang, Tao, Feng. 2022. Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). In Oncology letters, 24, 455. doi:10.3892/ol.2022.13575. https://pubmed.ncbi.nlm.nih.gov/36380875/
6. Chen, Xin, Wu, Xiaotang, Lei, Wen. 2020. USP44 hypermethylation promotes cell proliferation and metastasis in breast cancer. In Future oncology (London, England), 17, 279-289. doi:10.2217/fon-2020-0415. https://pubmed.ncbi.nlm.nih.gov/32956592/
7. Jiang, Wangjie, Yang, Xiao, Shi, Kuangheng, Li, Changxian, Li, Xiangcheng. 2023. MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex. In Oncogene, 42, 3344-3357. doi:10.1038/s41388-023-02849-6. https://pubmed.ncbi.nlm.nih.gov/37752233/
8. Liu, Yan, Yuan, Mengmeng, Xu, Xinxin, Yu, Wei, Ji, Meiju. 2024. USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21. In International journal of biological sciences, 20, 5223-5238. doi:10.7150/ijbs.99817. https://pubmed.ncbi.nlm.nih.gov/39430240/
9. Chen, Shuai, Wu, Kefan, Zong, Yingrui, Deng, Zhifen, Xia, Zongping. 2024. USP44 regulates HEXIM1 stability to inhibit tumorigenesis and metastasis of oral squamous cell carcinoma. In Biology direct, 19, 143. doi:10.1186/s13062-024-00573-z. https://pubmed.ncbi.nlm.nih.gov/39722007/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
